Sunday November 8 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Odontogenic Tumors

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Odontogenic Tumors:

Pubmed Logo
Nasal obstruction as the first symptom in a patient with a calcifying epithelial odontogenic tumour (CEOT).
Calcifying epithelial odontogenic tumour (CEOT), also known as Pindborg...
29th October, 2009
Division of Maxillofacial, Diagnostic, Medical and Surgical Sciences, UCL Dent Update. 2009 Jul-Aug;36(6):350-2, 355.
Critical role of heparin binding domains of ameloblastin for dental epithelium cell adhesion and ameloblastoma proliferation.
AMBN (ameloblastin) is an enamel matrix protein that regulates cell...
22nd October, 2009
Section of Pediatric Dentistry, Division of Oral Health, Growth and J Biol Chem. 2009 Oct 2;284(40):27176-84. Epub 2009 Jul 31.
DOI Direct Link
Pathology Quiz Case 1. Keratocystic odontogenic tumor (KCOT).
Keratocystic odontogenic tumors (KOTs) are distinct odontogenic lesions...
9th October, 2009
Pitie-Salpetriere University Hospital, University Paris 6 (Pierre et Marie Arch Otolaryngol Head Neck Surg. 2009 Sep;135(9):944, 946-7.
DOI Direct Link
Basal cell nevus syndrome: clinical and genetic diagnosis.
INTRODUCTION: Basal cell nevus syndrome (BCNS), also known as Gorlin-Goltz...
2nd October, 2009
Service of Oral and Maxillofacial Surgery, Albacete University Hospital Oral Maxillofac Surg. 2009 Oct 2.
DOI Direct Link
Mutation of ameloblastin gene in calcifying epithelial odontogenic tumor.
BACKGROUND: Ameloblastin (AMBN) gene expresses an important protein that...
1st October, 2009
Department of Oral Surgery and Pathology, Universidade Federal de Minas Anticancer Res. 2009 Aug;29(8):3065-7.

View more research publications.

Press Releases About Odontogenic Tumors:

BioPortfolio Logo
AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer 2nd November, 2009 AETERNA ZENTARIS INC.
Preliminary evaluation after completion of treatment phase shows that primary efficacy endpoint has been met for patients with advanced-stage platinum-resistant, taxane-pretreated ovarian
Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment 26th October, 2009 Reportlinker
-- A focus on "engineered" antibodies Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment reviews the broad drug development effort that is focused on bringing
Ascenta Therapeutics Announces Presentation of Results From a Dose-Ranging Study of AT-101 With Standard Therapy in Patients With Glioblastoma Multiforme 26th October, 2009 Ascenta Therapeutics, Inc.
MALVERN, Pa., Oct. 26 /PRNewswire/ -- Ascenta Therapeutics announced today that encouraging results from a Phase I dose-escalation study of two combination therapy regimens containing AT-101, an oral,
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer 23rd October, 2009 Onyx Pharmaceuticals, Inc.
WAYNE, N.J. and EMERYVILLE, Calif., Oct. 23 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced the companies have begun
NexGenix Pharmaceuticals Awarded Phase I Grant from the National Institute of Neurological Disorders and Stroke (NINDS) Small Business Innovation Research Program (SBIR) for the Development of Novel Small Molecule Hsp90 Therapeutics to Treat Glioma 22nd October, 2009 NexGenix Pharmaceuticals Holdings, Inc.
NEW YORK, Oct. 22 /PRNewswire/ -- NexGenix Pharmaceuticals Holdings, Inc. a privately-held biotechnology company with a portfolio of novel targeted therapies for oncology and neurodegenerative

BioNews Results for Odontogenic Tumors:

RSS Logo
BioPortfolio Logo
New PET Biomarker NVB-64 Visualizes Malignant Breast Tumors
Medicexchange.com:  Oct 30 2009 7:46PM Matching: tumors
New Positron Emission Tomography (PET) Biomarker NVB-64 Visualizes Malignant Breast Tumors
Medical News Today:  Oct 30 2009 2:47PM Matching: tumors
Medical News: New Positron Emission Tomography (PET) Biomarker NVB-64 Visualizes Malignant Breast Tumors
Medical News Today:  Oct 30 2009 11:49AM Matching: tumors
New Method Targets Cancerous Tumors Without Harming Healthy Cells
Science Daily:  Oct 30 2009 1:34AM Matching: tumors
New Positron Emission Tomography (PET) Biomarker NVB-64 Visualizes Malignant Breast Tumors
Reuters:  Oct 29 2009 6:44PM Matching: tumors
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Odontogenic Tumors Patents:

USPTO Logo
US Patent No.Title
7601700 Modulation of eIF4E expression
7183320 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
7250430 Thiophene-and thiazolesulfonamides as antineoplastic agents
7282595 Antitumor benzoylsulfonamides
7365153 Biologically active peptide and agent containing the same

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Odontogenic Tumors scientists - we have details of around 280 individuals working on Odontogenic Tumors .


This page has been viewed 464 times
Recent Search Terms used to find this page: odontogenic tumors | keratocystic odontogenic tumour | keratocystic odontogenic tumour | odontogenic tumors | Erupted odontomas a report of three cases and review of pdf | odontogenic tumors | odontogenic tumors | odontogenic tumors | odontogenic tumors | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Odontogenic Tumors across BioPortfolio, or for Odontogenic Tumors Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.